Sanjeev Narula - 06 Oct 2025 Form 4/A - Amendment Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: Chief Financial & Bus. Officer
Signature: /s/ Anne Marie Cook, Attorney-in-Fact for Sanjeev Narula
Issuer symbol: PHAT
Transactions as of: 06 Oct 2025
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 08 Oct 2025, 17:09:21 UTC
Date Of Original Report: 07 Oct 2025
Previous filing: 02 Apr 2025
Next filing: 02 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Narula Sanjeev	Chief Financial & Bus. Officer	C/O PHATHOM PHARMACEUTICALS, INC., 100 CAMPUS DRIVE, SUITE 102, FLORHAM PARK	/s/ Anne Marie Cook, Attorney-in-Fact for Sanjeev Narula	08 Oct 2025	0001820590

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Award	$0	+144,000		$0.000000	144,000	06 Oct 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted on October 6, 2025. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of October 6, 2025, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2	This amendment is being filed to report the transaction which was inadvertently omitted in the Form 4 filed on behalf of the Reporting Person on October 7, 2025.